Abstracts tagged "Ankylosing spondylitis (AS) and familial Mediterranean fever"

Abstract Number: 2616 • 2014 ACR/ARHP Annual Meeting
Comparison of Characteristics of Ankylosing Spondylitis in Association with Familial Mediterranean Fever with Those of Typical Ankylosing Spondylitis
Dilek Solmaz¹, Servet Akar², Bunyamin Kisacik³, Sule Apras⁴, Soner Senel⁵, Ahmet Mesut Onat³, Timucin Kasifoglu⁶, Kenan Aksu⁷, Ismail Sari⁸, Mehmet Akif Ozturk⁹, Mehmet Sayarlioglu¹⁰, Ali Akdogan⁴, Pinar Cetin⁸ and Nurullah Akkoc⁸, ¹Department of Internal Medicine, Division of Rheumatology, Namik Kemal University School of Medicine, Tekirdag, Turkey, ²Department of Internal Medicine, Division of Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey, ³Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁴Rheumatology, HacettepeUniversity School of Medicine, Ankara, Turkey, ⁵Rheumatology, Kayseri Erciyes University School of Medicine, Kayseri, Turkey, ⁶Rheumatology, Eskisehir OsmangaziUniversity School of Medicine, Eskisehir, Turkey, ⁷Rheumatology, Ege University School of Medicine, Izmir, Turkey, ⁸Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey, ⁹Rheumatology, GaziUniversity School of Medicine, Ankara, Turkey, ¹⁰Rheumatology, KahramanmarasSutçü ImamUniversity School of Medicine, Kahramanmaras, Turkey
Background/Purpose Several case reports and a few published studies suggest a link between Familial Mediterranean Fever (FMF) and ankylosing spondylitis (AS). There is very limited…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].